Trial Profile
Phase I trial of BIL-221s in patients with cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 21 May 2015
Price :
$35
*
At a glance
- Drugs BIL 221s (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors Biosceptre International
- 21 May 2015 New trial record